The New York Times 2004 Barry Meier - Abstracts

Title	Subject	Authors
The New York Times 2004 Barry Meier
A.M.A. Adds Its Voice to Call For Disclosure On Drug Trials.(Business/Financial Desk)	News, opinion and commentary	Barry Meier
Drug Maker Acknowledges Some Negative Test Results.(Business/Financial Desk)	News, opinion and commentary	Barry Meier
Earlier Merck Study Indicated Risks of Vioxx.(Business/Financial Desk)	News, opinion and commentary	Barry Meier
Flawed Device Places F.D.A. Under Scrutiny.(Business/Financial Desk)(defibrillators from Access Cardiosystems)	News, opinion and commentary	Barry Meier
For Merck, Defense of a Drug Crumbles at a Difficult Time.(Business/Financial Desk)(MERCK AND VIOXX: THE CLINICAL TESTS)	News, opinion and commentary	Barry Meier
Medical Editors Likely To Call for Registration Of Drug Tests at Outset.(Business/Financial Desk)	News, opinion and commentary	Barry Meier
New York's Pension Fund Files Own Suit Against Merck.(Business/Financial Desk)	News, opinion and commentary	Barry Meier
Questions Are Seen On Merck's Stance On Pain Drug's Use.(Business/Financial Desk)	News, opinion and commentary	Barry Meier

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.